Asahi Kasei Corporation

Asahi Kasei is a diversified Japanese industrial conglomerate with a significant global presence in three primary business sectors: Material (chemicals, fibers, electronics), Homes (housing and construction materials), and Health Care (pharmaceuticals, medical devices, and acute critical care). The Health Care segment, which includes Asahi Kasei Pharma and Asahi Kasei Therapeutics, focuses on specialty therapeutic areas such as immunology, kidney disease, transplantation, and severe infectious diseases. The company employs a strategy of mitigating development risks by focusing on specialty niche markets rather than blockbuster products, supported by active M&A and in-licensing activities.